Search Results 381-390 of 14450 for albumin

1. A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer - Mayo Clinic

   - Albumin ≥ 3.0 g/dL. - Aspartate aminotransferase (AST) serum glutamic oxaloacetic transaminase (SGOT) and/or alanine aminotransferase (ALT) serum ...

2. Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer. - Mayo Clinic

   Albumin ≥3.0 g/dL; 8. Acceptable coagulation parameters including international normalized ratio (INR) <1.5 and partial thromboplastin time (PTT) ...

3. A Study Comparing 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR to Treat Patients with Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours - Mayo Clinic

   Serum albumin < 3.0 g/dL unless prothrombin time is within the normal range. Pregnancy or lactation. For female patients of childbearing potential (defined ...

4. Publications - Mayo Clinic

   Additional Value of Preoperative Albumin for Surgical Risk Stratification among Colorectal Cancer Patients. Ann Nutr Metab. 2020; 76 (6):422-430 Epub 2021 ...

5. A Dose Escalation and Expansion Study of ASP4132 to Subjects With Advanced Refractory Tumors and Lymphoma - Mayo Clinic

   ... albumin ≤ 3.0 g/dL at Screening. Subject has any abnormalities in serum sodium, potassium, chloride, calcium and magnesium levels ≥ Grade 2 at screening ...

6. Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer - Mayo Clinic

   Albumin ≥ 3 g/dL; Negative pregnancy test done ≤ 7 days prior to registration, for women of childbearing potential only; Capable of understanding the ...

7. A Study to Evaluate Pembrolizumab with Standard Therapy to Treat Newly-diagnosed Glioblastoma - Mayo Clinic

   Albumin ≥ 2.5 mg/dL;; Total bilirubin ≤ 1.5 x ULN OR Direct bilirubin ≤ULN for patients with total bilirubin levels > 1.5 x ULN;; Aspartate transaminase ...

8. Study To Evaluate The Efficacy And Safety Of Elafibranor In Patients With Primary Biliary Cholangitis (PBC) And Inadequate Response To Ursodeoxycholic Acid - Mayo Clinic

   Albumin <3.5 g/dL; Presence of clinical complications of PBC or clinically significant hepatic decompensation, including: Current Model for End-Stage Liver ...

9. Skin Cancer Clinical Trials - Mayo Clinic Research

   Drugs used in chemotherapy, such as paclitaxel albumin-stabilized nanoparticle formulation, work in different ways to stop the growth of tumor cells, either by ...

10. A Study to Evaluate Glucagon Ready to Use (RTU) in Subjects With Hyperinsulinemic Hypoglycemia After Bariatric Surgery - Mayo Clinic

    ... albumin < 3.0 g/dL. Congestive heart failure, New York Heart Association Class III or IV. History of myocardial infarction, unstable angina, or ...